Although its role is still not fully understood, it can be speculated that LAG-3 expression on TAMs contributes to their tumor-promoting function, as suggested by the association of co-expression of CD163 and LAG-3 with poor clinicopathological indexes in melanoma [36] and metastatic ovarian cancer [61]. The gene discussed is LAG3; the disease is melanoma.